🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Analgesic Efficacy of Ultrasound Guided Transversalis Fascia Plane Block in Inguinal Lymph Node Dissection

RecruitingNAAges 18 Years - 65 YearsAllNational Cancer Institute, Egypt
NCT07331129 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Pain accompanying Inguinal lymph node dissection triggers a complex stress response leading to impairment of pulmonary, immunological and metabolic function. Opioids are the current gold standard drug for postoperative pain relief, however exposure to large doses lead to multiple side effects of varying significance such as nausea, vomiting, dizziness, constipation, respiratory depression, hypoventilation and sleep disordered breathing. Therefore, strategies other than opioids are recommended without sacrificing proper and effective analgesia, especially in cancer patients who are more susceptible to tolerance and addiction. Transversalis Fascia Plane Block is used in patients undergoing various surgeries like iliac crest bone harvesting, appendicectomy, cecostomy and inguinal hernia repair, often in combination with TAP block. The initial description of TFPB was with patients in the su

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. American society of anesthesiologists (ASA) class I and II. 2. Age ≥ 18 and ≤ 65 Years. 3. Cancer patients for inguinal lymph node dissection. 4. Body mass index (BMI): \> 20 kg/m2 and \< 40 kg/m2. Exclusion Criteria: 1. Patient refusal. 2. Local infection at the puncture site. 3. Coagulopathies with platelets count below 50,000 or an INR\>1.6. 4. Unstable cardiovascular disease. 5. History of psychiatric and cognitive disorders. 6. Patients allergic to medication used.
💊

What it tests

  • transversalis fascia plane block and surgical sit local anesthetic infiltration
📍

Where

1 site
National Cancer Institute Cairo University
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy